Biologic sales to pass innovative small molecules in next five years: GlobalData
According to GlobalData’s report, ‘Future of Pharma—Looking Ahead to 2022’, biologics are forecast to significantly overtake…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biologics
Lupin and Axantia enter into license-, supply- and technology-sharing agreement for Pegfilgrastim
Under the terms of the agreement, Axantia will register, distribute and market biosimilar Pegfilgrastim drug product in certain…
Growing opportunities in API manufacturing as innovative biologic approvals increase: GlobalData
CMOs can benefit from investing in capabilities and expertise to produce and handle sensitive biologics, as the marketed drugs…
WuXi Biologics to acquire CMAB Biopharma Group
Form strategic partnership with CBC Group
Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis
The company is focused on developing novel biologics and biosimilars
Thermo Fisher Scientific, Innoforce to set up biologics and steriles drug manufacturing facility in…
The new facility is expected to be completed in 2022
Lactiga and Mount Sinai sign pact to advance its patented biologic for COVID-19 treatment
The collaborative team secured an NIH R01 Emergency Award of $2 million dollars to expand this study
GE Healthcare Life Sciences to supply Akeso Biopharma with FlexFactory platform
Platform expected to be operational by end of 2020, create up to 150 jobs upon opening
The new realities in pharma R&D
It is pivotal for India’s pharma R&D playbook to evolve and become more agile and responsive with the help of technology and…
Biocon Q1FY20 Revenue grows by 25 per cent
EBITDA up 51 per cent at Rs 462 crores, net profit (excluding exceptional item) up 86 per cent at Rs 223 crores, small molecules…